NinePoint Medical
NinePoint Medical, Inc. is a medical device company specializing in advanced Optical Coherence Tomography (OCT) technology for real-time, high-resolution imaging of human tissue microstructure, particularly the esophagus. Their flagship product, the NvisionVLE Imaging System with Real-time Targeting™, provides volumetric laser endomicroscopy that captures detailed cross-sectional images up to 3mm deep with 7 micron resolution, enabling improved biopsy targeting and diagnostic evaluation during standard endoscopy procedures. The system integrates advanced imaging speed, resolution, and tissue marking capabilities to enhance clinical decision-making. NinePoint Medical serves academic and medical research communities and offers a large anonymized clinical dataset enhanced by AI/ML for pattern detection, supporting data analysis and research. The company is positioned as an innovator in esophageal surveillance imaging, leveraging licensed technology from Massachusetts General Hospital and targeting improved patient outcomes through enhanced diagnostic precision.
NinePoint Medical
NinePoint Medical, Inc. is a medical device company specializing in advanced Optical Coherence Tomography (OCT) technology for real-time, high-resolution imaging of human tissue microstructure, particularly the esophagus. Their flagship product, the NvisionVLE Imaging System with Real-time Targeting™, provides volumetric laser endomicroscopy that captures detailed cross-sectional images up to 3mm deep with 7 micron resolution, enabling improved biopsy targeting and diagnostic evaluation during standard endoscopy procedures. The system integrates advanced imaging speed, resolution, and tissue marking capabilities to enhance clinical decision-making. NinePoint Medical serves academic and medical research communities and offers a large anonymized clinical dataset enhanced by AI/ML for pattern detection, supporting data analysis and research. The company is positioned as an innovator in esophageal surveillance imaging, leveraging licensed technology from Massachusetts General Hospital and targeting improved patient outcomes through enhanced diagnostic precision.